News Breaks |
|
|
| January 17, 2013 |
| 09:45 EDT |  | ABT, ABT, THOR, THOR, TFX, TFX, SYK, SYK, STJ, STJ, NUVA, NUVA, MDT, MDT, HTWR, HTWR, HSP, HSP, EW, EW, COV, COV, CFN, CFN, BDX, BDX, BSX, BSX, BCR, BCR, BAX, BAX, ZMH, ZMH | Barclays' U.S. medical suppplies & devices analysts hold a conference call
U.S. Medical Supplies & Devices Research Team discuss key potential catalysts and top ideas for 2013 on an Analyst/Industry conference call. Relevant covered companies ABT, BAX, BCR, BSX, BDX, CFN, COV, EW, HSP, HTWR, MDT, NUVA, STJ, SYK, TFX, THOR and ZMH will be discussed on the Analyst/Industry conference call to be held January 17 at 10 am. |
|
|
News For ABT;BAX;BCR;BSX;BDX;CFN;COV;EW;HSP;HTWR;MDT;NUVA;STJ;SYK;TFX;THOR;ZMH From The Last 14 Days Check below for free stories on ABT;BAX;BCR;BSX;BDX;CFN;COV;EW;HSP;HTWR;MDT;NUVA;STJ;SYK;TFX;THOR;ZMH the last two weeks. |
|
|
| May 17, 2013 |
| 10:07 EDT |  | NUVA | On The Fly: Analyst Initiation Summary
 Subscribe for More Information |
|
| 10:07 EDT |  | ZMH, SYK | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Actuant (ATU) downgraded to Neutral from Buy at SunTrust... Aruba Networks (ARUN) downgraded to Perform from Outperform at Oppenheimer... CAE (CAE) downgraded to Sector Perform from Outperform at RBC Capital... City Holding (CHCO) downgraded to Market Perform from Outperform at Keefe Bruyette... Deere (DE) downgraded to Sell from Neutral at Goldman... Disney (DIS) downgraded to Neutral from Overweight at Atlantic Equities... HSBC (HBC) downgraded to Neutral from Outperform at Exane BNP Paribas... L Brands (LTD) downgraded to Underperform from Hold at Jefferies... Manning & Napier (MN) downgraded to Underperform from Neutral at BofA/Merrill... MeadWestvaco (MWV) downgraded to Underperform from Sector Perform at RBC Capital... National Grid (NGG) downgraded to Neutral from Outperform at Exane BNP Paribas... Savient (SVNT) downgraded to Market Perform from Outperform at William Blair... Stryker (SYK) downgraded to Reduce from Neutral at SunTrust... TRW Automotive (TRW) downgraded to Hold from Buy at Deutsche Bank... Universal Health (UHS) downgraded to Neutral from Positive at Susquehanna... Williams-Sonoma (WSM) downgraded to Neutral from Buy at BofA/Merrill... Zimmer (ZMH) downgraded to Reduce from Neutral at SunTrust... Aviva (AV) downgraded to Underperform from Sector Perform at RBC Capital... Pandora (P) downgraded to Hold from Buy at Maxim... Lumos Networks (LMOS) downgraded to Neutral from Buy at DA Davidson... Brocade (BRCD) downgraded to Underperform from Market Perform at William Blair... Applied Materials (AMAT) downgraded to Neutral from Buy at DA Davidson... Cosi (COSI) downgraded to Market Perform from Outperform at Northland Securities. |
|
| 08:55 EDT | | CFN | CareFusion has a conference call hosted by JPMorgan
JPMorgan's MedTech Analyst Weinstein hosts a conference call with CEO Gallahue on May 24 at 11 am. |
|
| 08:04 EDT |  | THOR | Thoratec announces FDA approval of HeartMate II Pocket Controller
Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. |
|
| 06:41 EDT | | NUVA | NuVasive initiated with a Buy at WallachBeth
Subscribe for More Information |
|
| 06:37 EDT | | ZMH | Zimmer downgraded to Reduce from Neutral at SunTrust
Subscribe for More Information |
|
| 06:22 EDT | | SYK | Stryker downgraded to Reduce from Neutral at SunTrust
Subscribe for More Information |
|
| May 16, 2013 |
| 16:13 EDT | | BSX | Vascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
| 13:32 EDT |  | MDT | Medtronic volatility flat into Q4 and outlook
Subscribe for More Information |
|
| 10:03 EDT | | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
| |
| 09:22 EDT | | CFN | CareFusion management to meet with Deutsche Bank
Meeting to be held in Toronto on May 16 hosted by Deutsche Bank. |
|
| 08:05 EDT | | STJ | St. Jude Medical's 3-D vessel reconstruction system approved in Europe
St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. |
|
| 07:51 EDT |  | BSX | Boston Scientific price target raised to $12 from $9 at JMP Securities
JMP Securities increased its price target on Boston Scientific as the firm believes after speaking with experts that S-ICD devices can be used in 50% of de novo implant cases, up from its previous estimate of 30%. The firm's FY13 and FY14 earnings estimates for the company are well above consensus levels and it reiterates an Outperform rating on the shares. |
|
| 07:28 EDT | | COV, BSX, CFN | I/O Central to host a conference
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 15, 2013 |
| 09:22 EDT | | CFN | CareFusion management to meet with Deutsche Bank
Meeting to be held in Montreal on May 15 hosted by Deutsche Bank. |
|
| 07:17 EDT | | EW | Edwards Lifesciences share repurchases positive, says Wells Fargo
Subscribe for More Information |
|
| May 14, 2013 |
| 15:33 EDT | | BSX | Boston Scientific has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Mike Mahoney on May 17 at 11 am. |
|
| 09:27 EDT | | EW | Edwards Lifesciences CEO to purchase $5M of company stock
The company announced that Michael A. Mussallem, Edwards' chairman and CEO, will make a $5M cash purchase of newly issued shares of Edwards common stock. |
|
| 09:26 EDT | | EW | Edwards Lifesciences announces new $750M share repurchase program
Edwards Lifesciences announced that its board has authorized a new share repurchase program to acquire up to an additional $750M of the company's outstanding common shares. As of March 31, Edwards had approximately $140M remaining of its current $500M share repurchase program, which was authorized in September 2011. Edwards expects to utilize the remainder of the $500M repurchase authorization during Q2. |
| |
|
|
|
|
